Septerna, Inc. (SEPN)
38.96
-0.17
(-0.43%)
USD |
NASDAQ |
Oct 01, 13:22
Septerna Price to Book Value : 4.601 for Oct. 1, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.621 |
| September 29, 2026 | 4.621 |
| September 28, 2026 | 4.693 |
| September 25, 2026 | 4.460 |
| September 24, 2026 | 4.503 |
| September 23, 2026 | 4.540 |
| September 22, 2026 | 4.768 |
| September 21, 2026 | 4.551 |
| September 18, 2026 | 4.569 |
| September 17, 2026 | 4.664 |
| September 16, 2026 | 4.539 |
| September 15, 2026 | 4.589 |
| September 14, 2026 | 4.670 |
| September 11, 2026 | 4.548 |
| September 10, 2026 | 4.458 |
| September 09, 2026 | 4.484 |
| September 08, 2026 | 4.413 |
| September 04, 2026 | 4.340 |
| September 03, 2026 | 4.346 |
| September 02, 2026 | 4.428 |
| September 01, 2026 | 4.450 |
| August 31, 2026 | 4.505 |
| August 28, 2026 | 4.595 |
| August 27, 2026 | 4.779 |
| August 26, 2026 | 4.753 |
| Date | Value |
|---|---|
| August 25, 2026 | 4.877 |
| August 24, 2026 | 4.785 |
| August 21, 2026 | 4.724 |
| August 20, 2026 | 4.817 |
| August 19, 2026 | 5.188 |
| August 18, 2026 | 5.172 |
| August 17, 2026 | 5.220 |
| August 14, 2026 | 5.255 |
| August 13, 2026 | 5.330 |
| August 12, 2026 | 5.691 |
| August 11, 2026 | 5.640 |
| August 10, 2026 | 4.588 |
| August 07, 2026 | 4.585 |
| August 06, 2026 | 4.668 |
| August 05, 2026 | 4.577 |
| August 04, 2026 | 4.603 |
| August 03, 2026 | 4.131 |
| July 31, 2026 | 4.068 |
| July 30, 2026 | 4.154 |
| July 29, 2026 | 3.969 |
| July 28, 2026 | 4.012 |
| July 27, 2026 | 3.955 |
| July 24, 2026 | 3.909 |
| July 23, 2026 | 3.952 |
| July 22, 2026 | 4.039 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 15.19 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8850 |
| Fulcrum Therapeutics, Inc. | 0.9073 |
Price to Book Value Related Metrics
| PS Ratio | 17.73 |
| Price to Free Cash Flow | 16.68 |
| Price | 38.96 |
| Earnings Yield | -1.40% |
| Market Cap | 1.779B |